Patent ID: 8871721
Filing Date: 2014-10-28
Classification: A61K,A61P,G01N

Abstract:
1. A method for inhibiting a peritoneal dissemination of a cancer cell of a patient, the cancer cell being one selected from a group consisting of a gastric cancer, a small intestine cancer, a colon cancer, a rectal cancer, an ovary cancer, an appendiceal cancer and a pancreatic cancer, comprising a step of: administering to the patient an effective dose pharmaceutical composition, comprising a connective tissue growth factor (CTGF) and/or an active fragment thereof, wherein the CTGF and/or the active fragment thereof inhibits the cancer cell adhering to the peritoneal cavity or the formation of a peritoneal nodule, and the pharmaceutical composition is administered in one of two ways: once per two days for at least 14 days and once per day for at least 7 days.